Implementation of PDE setting for drug substance (Progress of PDE setting roundtable activity)
-
- HASEGAWA Tomoyuki
- ONO Pharmaceutical Co., Ltd.
-
- MATSUNAGA Shinichiro
- Takeda Pharmaceutical Company Limited
-
- IKEMOTO Keiko
- Takeda Pharmaceutical Company Limited
-
- KATO Nobuaki
- CHUGAI PHARMACEUTICAL CO., LTD.
-
- HIRASAWA Daisuke
- CHUGAI PHARMACEUTICAL CO., LTD.
-
- TSUNENARI Ichiro
- Safety Evaluation Forum
-
- SUZUKI Mutsumi
- Kyowa Hakko Kirin Co., Ltd.
-
- MOGI Hiroyuki
- SANTEN PHARMACEUTICAL CO., LTD.
-
- KOZAKI Masato
- Kowa Company. Ltd.
-
- NAKAZAWA Akiko
- Sumika Chemical Analysis Service, Ltd.
-
- YOSHIOKA Kaoru
- Sumika Chemical Analysis Service, Ltd.
-
- HAYASHI Tae
- Chemicals Evaluation and Research Institute, Japan
-
- FUKUSHIMA Asako
- Chemicals Evaluation and Research Institute, Japan
-
- HORINOUCHI Akira
- SPERA PHARMA, Inc
-
- OTA Tsutomu
- SPERA PHARMA, Inc
-
- NAKAJIMA Ayako
- NISSAN CHEMICAL INDUSTRIES, LTD
-
- YAMAURA Yuji
- ASAHI KASEI FINECHEM CO., LTD.
-
- TAKEDA Morihiko
- Pharma Solutions Co., Ltd.
-
- HATTORI Munetaka
- Pharmaceutical Consultant
Bibliographic Information
- Other Title
-
- 医薬品原薬のPDE設定の具現化（PDE設定検討会の活動進捗）
Abstract
<p>[in Japanese] </p>
Journal
-
- Annual Meeting of the Japanese Society of Toxicology
-
Annual Meeting of the Japanese Society of Toxicology 46.1 (0), W1-3-, 2019
The Japanese Society of Toxicology
- Tweet
Details 詳細情報について
-
- CRID
- 1390845713082789632
-
- NII Article ID
- 130007677687
-
- Text Lang
- ja
-
- Data Source
-
- JaLC
- CiNii Articles
-
- Abstract License Flag
- Disallowed